$BUD

What's Going on With Anheuser-Busch InBev Stock Thursday? - Anheuser-Busch InBev (NYSE:BUD)

Anheuser-Busch InBev reported adjusted EPS of $1.21 vs $1.11 and sales of $16.66B vs $16.352B. Revenue rose 11% YoY, organic revenue grew 5.6%, and profit attributable to shareholders more than doubled to $3.75B. Volumes rose 0.9%. The company kept 2026 EBITDA growth guidance of 4% to 8% and said the 2026 FIFA World Cup added modest volume support.

Original reporting
Published Jul 30, 2026, 4:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 5:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
What's Going on With Anheuser-Busch InBev Stock Thursday? - Anheuser-Busch InBev (NYSE:BUD) — source image
Decision brief

The 30-second read

$BUDBullishMed
01

Why it matters

The key tradable inputs are the EPS and sales beats, the maintained EBITDA growth and capex guidance, and the explicit regional divergence (Americas strength vs China decline).

02

Market read

This is a post-earnings update with maintained guidance, likely driving near-term positioning, while China weakness and earnings quality details shape the risk debate.

03

What to watch

Traders may underweight the quality of earnings (non-underlying gains) and overemphasize the World Cup as a one-off, despite management framing it as a longer-term launchpad for Michelob ULTRA.

Relevance 7/10Novelty 7/10Timing: post-earnings, published Thursday at 16:15 UTC

Background

The piece summarizes AB InBev’s quarterly results, regional performance, cash flow, buyback progress, and its maintained 2026 outlook.

Company-level read

Ticker impact

$BUDBullishMedium confidence
Context

AB InBev reported adjusted EPS of $1.21 and sales of $16.66B, beating estimates, and maintained 2026 EBITDA growth guidance.

Expected impact

Mildly positive bias for the next session, with traders focusing on organic growth, China volumes, and whether guidance is credible.

Evidence & confidence

The article provides concrete earnings beats, cash flow and buyback progress, and a maintained outlook, but also highlights China revenue and EBITDA declines and non-underlying derivative gains.

Market effects

Beer category demand signals remain supportive via volume growth and megabrand execution, but China channel softness is a caution flag for peers.

Americas strength (including World Cup-driven volume) contrasts with China weakness tied to weather and on-premise conditions.

Currency translation and macro inflation assumptions are explicitly referenced, which can influence how investors model multinational consumer staples earnings.

Counterpoint

Underlying profit and organic revenue growth are positive, but the quarter’s headline profit includes $1.40B of non-underlying derivative mark-to-market gains, and China deterioration could offset Americas strength.

Key entities

  • Anheuser-Busch InBev

    Reported adjusted EPS and sales beats, discussed World Cup volume contribution, highlighted China weakness, and maintained 2026 outlook.

  • Michel Doukeris

    CEO quoted on performance drivers, World Cup impact, and Michelob ULTRA expansion.

Related articles

$MSFTHighAI 8/10

Stocks making the biggest moves premarket: Meta, Microsoft, Teladoc, Norwegian Cruise Line & more

Premarket movers include Microsoft shares up about 9% after quarterly revenue of $90.01B beat estimates and Azure grew 43% at constant currency, with 2026 Azure revenue forecast above $100B. Meta fell nearly 9% on EPS and revenue forecast misses. Other notable moves: Teladoc -18.5%, Norwegian Cruise Line -7%, Starbucks +6%, Carvana -10%, MarketAxess halted on a $167/share buyout by ICE.

$BUDMed

AB InBev Reports Second Quarter 2026 Results

AB InBev reported 2Q26 results, saying revenue rose 5.6% and beer volumes grew 1.1%. Underlying EPS increased 23.4%. EBITDA was up 5.8% and free cash flow rose to $3.9 billion, up $2.5 billion vs HY25. Net debt to EBITDA improved to 2.86x. BEES Marketplace GMV rose 50% to $1.2 billion.

$BUDMed

Stay away from this beer giant as Brazil 'sin tax' and post-World Cup hangover weigh on the stock, says Barclays

Barclays downgraded Anheuser-Busch InBev (ABI) to equal weight from overweight, citing Brazil’s planned “sin tax” on health-harming goods and post-2026 World Cup demand comparisons. Analyst Laurence Whyatt said Brazil Beer is about 11% of ABI revenue and 48% of Ambev EBITDA, with the tax starting Jan 2027. Barclays also flagged ABI’s valuation above peers.

$BUDMedAI 8/10

Anheuser-Busch InBev SA/NV (BUD): A Top Sin Stock to Buy Amid Expansion Plans

Anheuser-Busch InBev said May 13 it will invest $5 million to expand its Columbus, Ohio brewery to boost production of Michelob ULTRA and Michelob ULTRA Zero, as part of a $600 million “Brewing Future” initiative. The company reported 1Q revenue up 5.8% and EPS up 20.8% to $0.97, citing costs and FX. Full-year EBITDA is expected to rise within a 4%-8% medium-term range.

$SHOPMedAI 8/10

Shopify Was Supposed to Be an AI Casualty. Its AI-Referred Traffic Just Tripled.

Shopify (SHOP) reported Q2 results, citing AI-referred traffic to merchants’ storefronts that tripled year over year and orders that began with AI search also tripled. New buyers from AI channels placed orders at nearly twice the rate of other channels. Revenue rose 34% to $3.6B, GMV reached $115.6B, operating income rose 68% to $488M, and free cash flow was $654M.